OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
Antonino Glaviano, Seth A. Wander, Richard D. Baird, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101103-101103
Open Access | Times Cited: 14
Antonino Glaviano, Seth A. Wander, Richard D. Baird, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101103-101103
Open Access | Times Cited: 14
Showing 14 citing articles:
Identification of the novel exhausted T cell CD8 + markers in breast cancer
Hengrui Liu, Angela Dong, Ayana Meegol Rasteh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Hengrui Liu, Angela Dong, Ayana Meegol Rasteh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Molecular principles underlying aggressive cancers
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
Nie Zhang, Zhuoying He, Xuejin Qin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Nie Zhang, Zhuoying He, Xuejin Qin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Targeted degradation of CDK4/6 by LA-CB1 inhibits EMT and suppresses tumor growth in orthotopic breast cancer
Jingliang He, Shunfang Liu, Siyi Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Jingliang He, Shunfang Liu, Siyi Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Distinct allosteric networks in CDK4 and CDK6 in the cell cycle and in drug resistance
Wengang Zhang, D. Michael Bradburn, Gretchen Heidebrink, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Wengang Zhang, D. Michael Bradburn, Gretchen Heidebrink, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Distinct allosteric networks in CDK4 and CDK6 in the cell cycle and in drug resistance
Wengang Zhang, D. Michael Bradburn, Gretchen Heidebrink, et al.
Journal of Molecular Biology (2025), pp. 169121-169121
Open Access
Wengang Zhang, D. Michael Bradburn, Gretchen Heidebrink, et al.
Journal of Molecular Biology (2025), pp. 169121-169121
Open Access
Integrative analysis of m6A-SNPs and single-cell RNA sequencing reveals key drivers of endocrine combined with CDK4/6 inhibitor therapy resistance in ER+ breast cancer
Ruijie Ming, Han Zhang, Huan Wu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Ruijie Ming, Han Zhang, Huan Wu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Anticancer Potential of Prebiotics: Targeting Estrogen Receptors and PI3K/AKT/mTOR in Breast Cancer
Hussein Sabit, Sama Abouelnour, Bassel M. Hassen, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 990-990
Open Access
Hussein Sabit, Sama Abouelnour, Bassel M. Hassen, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 990-990
Open Access
CELL CYCLE DYSREGULATION IN CANCER
Antonino Glaviano, Samarendra Kumar Singh, E. Hui Clarissa Lee, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100030-100030
Closed Access | Times Cited: 2
Antonino Glaviano, Samarendra Kumar Singh, E. Hui Clarissa Lee, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 2, pp. 100030-100030
Closed Access | Times Cited: 2
Patient with hormone receptor‑positive Her2‑negative metastatic breast cancer with visceral crisis with good response to abemaciclib and letrozole: A case report and review of the literature
Yongmei Wang, Xueqing Zou, Yan Mao, et al.
Molecular and Clinical Oncology (2024) Vol. 21, Iss. 6
Open Access | Times Cited: 1
Yongmei Wang, Xueqing Zou, Yan Mao, et al.
Molecular and Clinical Oncology (2024) Vol. 21, Iss. 6
Open Access | Times Cited: 1
Fasting-mimicking diet potentiates anti-tumor effects of CDK4/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling
Ning Li, Yajie Sun, Li-Yun Huang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101161-101161
Closed Access | Times Cited: 1
Ning Li, Yajie Sun, Li-Yun Huang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101161-101161
Closed Access | Times Cited: 1
Using bioinformatics and artificial intelligence to map the cyclin-dependent kinase 4/6 inhibitor biomarker landscape in breast cancer
Kim Wager, Yao Wang, Andrew T. F. Liew, et al.
Future Oncology (2024), pp. 1-19
Open Access
Kim Wager, Yao Wang, Andrew T. F. Liew, et al.
Future Oncology (2024), pp. 1-19
Open Access
CDK4/6 inhibitors in HR-positive breast cancer immunotherapy
Minqian Shen, Zhiyuan Ma, Jiaxing Zhu, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108095-108095
Open Access
Minqian Shen, Zhiyuan Ma, Jiaxing Zhu, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108095-108095
Open Access
